Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 2 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Lung Neoplasms 1 Colorectal Neoplasms 1

Interventions

Fluorouracil 71 pembrolizumab 62 Bevacizumab 60 Oxaliplatin 59 Cetuximab 59 Leucovorin 56 Irinotecan 55 Capecitabine 31 Nivolumab 23 Gemcitabine 18 Cisplatin 18 IFL protocol 17 Folfox protocol 17 Cyclophosphamide 16 Carboplatin 15 atezolizumab 14 Specimen Handling 14 Paclitaxel 14 Magnetic Resonance Spectroscopy 14 Biopsy 14 trifluridine tipiracil drug combination 12 Pemetrexed 10 spartalizumab 9 regorafenib 9 fludarabine 9 Panitumumab 9 130-nm albumin-bound paclitaxel 9 trametinib 8 durvalumab 8 dehydroftorafur 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Colorectal Neoplasms × Oxycodone × Clear all

NCT03253133 2023-05-03

NIPOX

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡